Jefferies Initiates Dicerna Pharmaceuticals At Buy By: Benzinga via Benzinga May 29, 2015 at 08:28 AM EDT Analysts at Jefferies initiated coverage on Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) with a Buy rating. The target price for ... Read More >> Related Stocks: Dicerna Pharmaceutic